Three Dividend Kings Have Kept Raising Payouts Through Decades of Recessions
The article highlights Procter & Gamble, Johnson & Johnson, and Coca-Cola as companies that have increased dividends through multiple economic downturns since the 1960s. It notes their combined free cash flow is about $48 billion, which comfortably covers dividend obligations. However, Johnson & Johnson faces pressure from a nearly 60% drop in Stelara sales due to biosimilar competition.
Procter & Gamble’s current quarterly dividend is $1.0885, equal to $4.354 annualized, with a 2.98% trailing yield. In fiscal 2026 it produced $19.56 billion in operating cash flow and $15.84 billion in free cash flow, up 12.74%, while management outlined about $10 billion of dividends and $5 billion of buybacks for fiscal 2027.
Johnson & Johnson lifted its quarterly payout 3.1% to $1.34 in April 2026, continuing a 64-year streak. Coca-Cola’s record stretches to the Kennedy administration. The three companies’ combined free cash flow is roughly $48 billion, covering their dividends many times, though JNJ’s Stelara sales fell almost 60% amid biosimilar competition.
Income-focused investors, including retirees, may see these long payout records as reassurance during downturns. If Johnson & Johnson’s Stelara decline pressures future dividends, patients, employees, and shareholders could feel indirect effects. Stable payouts from large consumer and healthcare companies can help household budgets and pension portfolios, while capital-allocation choices may influence research spending and market confidence. How savers judge defensive stocks could shift accordingly.